...Hello, everybody. Thank you for joining us today. This is Tim Long at Barclays, along with Elisa Shreves on my team. We are happy to have Corning with us for this 9:10 presentation. With Corning, we have Brendan Mosher, VP and General Manager of Corning Pharmaceutical Technologies; and Ann Nicholson, VP, Investor Relations. So we hope to get a good insight on the Life Sciences business as well as some of the other key end markets that Ann might chime in on as well. So first, I'm going to throw it over to Brendan to give us a little bit of an overview, and then we'll dive into Q&A. Brendan Mosher All right. Well, thank you, Tim. Appreciate the introduction. As Tim said, I am Brendan Mosher, the Vice President and General Manager of Corning Pharmaceutical Technologies. And just a reminder that today, we'll be making some forward-looking statements and you should review our filings and our website to see any potential reasons that actual results may differ materially from the perspectives...